References
- BECKMANN, R . P.,MIZZEN, L. A., and WELCH, W. J., 1989, Interaction of Hsp 70 with newly synthesized proteins: Implications for protein folding and assembly. Science, 248, 850–854.
- BLACHERE, N. E., UDONO, H., JANETZKI, S., LI, Z., HEIKE, M and SRIVASTAVA, P. K., 1993, Heat shock protein vaccines against cancer. Journal of Immunotherapy, 14, 532–536.
- DAVIES, C. DE. L., RANHEIM, T., MALIK, Z., ROFSTAD, E. K., MOAN, J., and LINDMO, T., 1988, Relationship between changes in antigen expression and protein synthesis in human melanoma cells after hyperthermia and photodynamic treatment British Journal of Cancer, 58, 306–313.
- DENAGEL, D. C., and PIERCE, S. K., 1990, Heat shock proteins in immune responses. Critical Review of Immunology, 13, 71–81.
- FIDLER, I. J., and KRIPKE, M. L., 1980, Tumor cell antigenicity, host immunity, and cancer metastasis. Cancer Immunology and Immunotherapy, 7, 201–205.
- GOLUMBEK, P. T., AZHARI, R., JAFFEE, E. M., LEVITSKY, H. I., LAZENBY, A., LEONG, K., and PARDOLL, D. M., 1993, Controlled release, biodegradable cytokine depots: A new approach in cancer vaccine design. Cancer Research, 53, 5841–5844.
- HELLSTRöM, I., and HELLSTRöM, K. E., 1993, Tumor immunology An over view. Annals of the New York Academy of Sciences, 690, 24–33.
- HOON, D . S. B., YUZUKI, D .,HAYASHIDA, M., and MORTON, D . L., 1995, Melanoma patients immunized with melanoma cell vaccine induced antibody response to recombinant MAGE-1 antigen. Journal of Immunology, 154, 730–737.
- HOUGHTON, A.N.,1994, Cancer antigens: Immune recognition of self and altered self. Journal of Experimental Medicine, 180, 1–4.
- KAUFMANN, S. H. E., 1990, Heat shock proteins and immune response. Immunology Today, 11, 129–136.
- LAEMMLI, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685.
- LINDQUIST, S., 1986, The heat shock response. Annual Review of Biochemistry, 55, 1151–1191.
- LINDQUIST, S., and CRAIG, E. A., 1988, The heat shock proteins. Annual Reviews of Genetics, 22, 631–677.
- LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L., and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275. LYDYARD, P. M., and VAN EDEN, W., 1990, Heat shock proteins: immunity and immuno- pathology. Immunology Today, 11, 228–229.
- MAASS, G., SCHMIDT, W., BERGER, M SCHILCHER, F., KOSZIK, F., SCHNEEBERGER, A., STINGL, G., BIRNSTIEL, M . L., and ScHwEioHoFFIR,T.,1995, Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: Three consecutive stages may be required for successful tumor vaccination. Proceedings of the National Academy of Sciences, USA, 92, 5540–5544.
- MEISENHELDER, J., and HUNTER, T., 1988, Radioactive protein-labelling techniques Nature, 335, 120.
- MÉNORET, A., PATRY, Y., BURG, C., and PENDU, J. L., 1995, Co-segregation of tumor im-munogenicity with expression of inducible but not constitutive hsp70 in rat colon car-cinoma. Journal of Immunology, 155, 740–747.
- MoNoovi, B., SANTORO, A. S., STROM, R., FAIOLA, R., and FANELLI, A. R., 1972, Increased immunogenicity of Ehrlich ascites cells after heat treatment Cancer, 30, 885–888.
- OZDEMIRLI M., AKDENIZ, H., EL-KHATIB, M., and Ju, S.-T., 1991, A novel cytotoxicity of CD4- Th1 clones on heat-shocked tumor targets. I. Implications for internal disinte-gration model for target death and hyperthermia treatment of cancers. Journal of Immunology, 147, 4027–4034.
- RITOSSA, F. A., 1962, New puffing pattern induced by temperature shock and DNP in Drosophila. Experimentia, 18, 571–573.
- SAMBROOK, J., and GETHING, M .-J., 1989, Chaperones, paperonese. Nature, 342, 224–225. SCHMIDT, W., SCHWEIGHOFFER, T., HERBST, E., MAASS, G., BERGER, M SCHILCHER, F.,
- SHHAFFNER, G., and BIRNSTIEL, M. L., 1995, Cancer vaccines: The interleukin 2 dosage effect. Proceedings of the National Academy of Sciences, USA, 92, 4711–4714.
- SRIVASTAVA, P. K., and MAKI, R. G., 1991, Stress-induced proteins in immune response to cancer. Current Topics in Microbiology and Immunology, 167, 109–123.
- TAMURA, Y TSUBOI, N., SATO, N., and KIKUCHI, K., 1993, 70 kDa heat shock cognate protein is a transformation-associated antigen and a possible target for the host's anti-tumor immunity. Journal of Immunology, 151, 5516–5524.
- THOMSON, S. A., KHANNA, R GARDNER, J., BURROWS, S. R COUPAR, B., Moss, D. J., and SUHRBIER, A., 1995, Minimal epitopes expressed in recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design. Proceedings of the National Academy of Sciences, USA, 92, 5845–5849.
- UDONO, H., and SRIVASTAVA, P. K., 1993, Heat shock protein 70-associated peptides elicit specific cancer immunity. Journal of Experimental Medicine, 178, 1391–1396.
- UDONO, H., LEVEY, D. L., and SRIVASTAVA, P. K., 1994, Cellular requirements for tumor-specific immunity elicited by heat shock proteins: Tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proceedings of the National Academy of Sciences, USA, 91, 3077–3081.
- ULLRICH, S. J., ROBINSON, E. A., LAW, L. W., WILLINGHAM, M., and APPELLA, E., 1986, A mouse tumor-specific transplantation antigen is a heat shock-related protein. Proceedings of the National Academy of Sciences, USA, 83, 3121–3125.
- VANBUSKIRK, A., CRUMP,B.L., MARGOLIASH, E., and PIERCE, S. K., 1989, A peptide binding protein having a role in antigen presentation is a member of the HSP70 heat shock family. Journal of Experimental Medicine, 170, 1799–1809.
- WILDER, R. B., LANGMUIR, V. K., MENDONCA, H. L., GORIS, M. L., and KNOX, S. J., 1993, Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts. Cancer Research, 53, 3022–3027.
- YOUNG, R. A., 1990, Stress proteins and immunology. Annual Review of Immunology, 8, 401–420.
- YOUNG, R. A., and ELLIOTT, T. J., 1986, Stressproteins, infection, and immune surveillance. Cell, 59, 5–8.